EVFM - D :: New Product (Phexxi)

NASDAQ:EVFM   Evofem Biosciences, Inc
Evofem's flagship product is Phexxi which is approved by the food and drug administration and is the first and only hormone-free prescription contraceptive "privacy"gel. As well, the company has several products in development, including EVO100, which is another privacy gel designed to reduce chlamydia and gonorrhea in women.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.